For a chance to hear Dr. Koffman’s opinions on 6 quick topics, visit here. About the author Brad Hedrick Related postsiwCLL 2019: Dr. Nicole Lamanna on biomarker testing for chronic lymphocytic leukemia (CLL)January 29, 2021iwCLL 2019: Dr. Anthony Mato on risk factors for tumor lysis syndrome in chronic lymphocytic leukemia (CLL)January 13, 2021iwCLL 2019: Dr. Constantine Tam on clonal evolution in chronic lymphocytic leukemia (CLL)December 30, 2020ASH 2019: Dr. Constantine Tam Discusses Captivate Trial – Ibrutinib + Venetoclax in First-Line TreatmentDecember 28, 2020ASH 2019: Dr. Allan Discusses a New Bruton’s Tyrosine Kinase (BTK) Inhibitor Currently in Phase I TrialsDecember 11, 2020iwCLL 2019: Dr. Maloney on “Off the Shelf” CAR-T cells for Chronic Lymphocytic Leukemia (CLL)December 7, 2020
iwCLL 2019: Dr. Nicole Lamanna on biomarker testing for chronic lymphocytic leukemia (CLL)January 29, 2021
iwCLL 2019: Dr. Anthony Mato on risk factors for tumor lysis syndrome in chronic lymphocytic leukemia (CLL)January 13, 2021
iwCLL 2019: Dr. Constantine Tam on clonal evolution in chronic lymphocytic leukemia (CLL)December 30, 2020
ASH 2019: Dr. Constantine Tam Discusses Captivate Trial – Ibrutinib + Venetoclax in First-Line TreatmentDecember 28, 2020
ASH 2019: Dr. Allan Discusses a New Bruton’s Tyrosine Kinase (BTK) Inhibitor Currently in Phase I TrialsDecember 11, 2020
iwCLL 2019: Dr. Maloney on “Off the Shelf” CAR-T cells for Chronic Lymphocytic Leukemia (CLL)December 7, 2020